Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
14.5 EUR | +5.07% | +18.08% | +101.39% |
04-17 | Medincell: share price rises following agreement with AbbVie | CF |
04-16 | Medincell, AbbVie to Co-Develop Injectable Therapeutics | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+101.39% | 425M | |
+35.81% | 664B | |
+29.51% | 567B | |
-7.16% | 354B | |
+19.60% | 330B | |
+4.51% | 286B | |
+13.57% | 234B | |
+5.26% | 199B | |
-9.90% | 196B | |
-4.59% | 148B |
- Stock Market
- Equities
- MEDCL Stock
- News MedinCell S.A.
- MedinCell S A : Kicks Off Regulatory Preclinical Development of Three New Treatments